Disseminated Visceral Fusariosis Treated with Amphotericin B-Phospholipid Complex

References

• Anaissie E., Kantarjian H., Jones P., Barlogie B., Luna M., Lopez-Berestein G., Bodey G. P. Fusarium. A newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986; 57: 2141–2145
   PubMed Web of Science ®Google Scholar
• Minor R. L., Jr, Pfaller M. A., Bingrich R. D., Burns L. J. Disseminated Fusarium infections in patients following bone marrow transplantation. Bone Marrow Transplant 1989; 4: 653–658
   PubMed Web of Science ®Google Scholar
• Richardson S. E., Bannatyne R. M., Summerbell R. C., Milliken J., Gold R., Weitzman S. S. Disseminated fusarial infection in the immunocompromised host. Rev. Infect. Dis. 1988; 10: 1171–1181
   PubMedGoogle Scholar
• Venditti M., Micozzi A., Gentile G., Palomellr L., Morace G., Bianco P., Avvisati G., Papa G., Martino P. Invasive Fusarium solani infections in patients with acute leukemia. Rev. Infect. Dis. 1988; 10: 653–660
   PubMedGoogle Scholar
• Anaissie E., Kantarjian H., Ro J., Hopfer R., Rolston K., Fainstein V., Bodey G. The emerging role of. Fusarium 1988; 67: 77–83, infections in patients with cancer. Medicine (Baltimore)
   Google Scholar
• Summerbell R. C., Richardson S. E., Kane J. Fusarium proli as an agent of disseminated infection in an immunosuppressed patient. J. Clin. Microbiol 1988; 26: 82–87
   PubMed Web of Science ®Google Scholar
• Blazar B. R., Hurd D. D., Snover D. C., Alexander J. W., McGlave P. B. Invasive Fusarium infections in bone marrow transplant recipients. Am. J. Med. 1984; 77: 645–651
   PubMed Web of Science ®Google Scholar
• Merz W. G., Karp J. E., Hoagland M., Jett-Goheen M., Junkins J. M., Hood A. F. Diagnosis and successful treatment of fusariosis in the compromised host. J. Infect. Dis. 1988; 158: 1046–1055
   PubMed Web of Science ®Google Scholar
• Kiehn T. E., Nelson P. A., Bernard E. M., Edwards F. F., Koziner B., Armstrong D. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J. Clin. Microbiol 1985; 21: 501–504
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Fainstein V., Hopfer R, et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer. A preliminary study. J. Infect. Dis. 1985; 151: 704–710
   PubMed Web of Science ®Google Scholar
• Silvius J. R. In. Lipid Protein Interactions, P. C. Jost, O. H. Griffith. Wiley, New York 1982; volume 2, Chapter, 7
   Google Scholar
• Amselem S., Gabizon A., Barenholz Y. Optimization and upscaling of doxorubicin containing liposomes for clinical use. J. Pharm. Sci. 1990; 79: 1045–1052
   PubMed Web of Science ®Google Scholar
• Ehle Nilsson, Yoshikawa T. T., Edwards J. E., Schotz M. C., Guze L. B. Quantitation of amphotericin B with use of high pressure chromatography. J. Infect. Dis. 1977; 135: 414–421
   PubMed Web of Science ®Google Scholar
• Kaplan W. Direct fluorescent antibody tests for the diagnosis of mycotic diseases. Ann. Clin. Lab. Sci. 1973; 3: 25–29
   PubMedGoogle Scholar
• Rhiem H., Feickert H. J., Lampert F. Acute lymphoblastic leukemia: cancer in children, clinical management, 2nd ed. Springer-Verlag, New York 1986
   Google Scholar
• Okuda C., Ito M., Sato Y., Oka K., Hotchi M. Disseminated cutaneous Fusarium infection with vascular invasion in a leukemic patient. J. Med. Vet. Mycol 1987; 25: 177–186
   PubMedGoogle Scholar
• Bodey G. P., Bolivar R., Fainstein V. Infectious complications in leukemic patients. Semin. Hematol. 1982; 19: 193–226
   PubMed Web of Science ®Google Scholar
• Estey E. H., Keating M. J., McCredie K. B., Bodey G. P., Freireich E. J. Causes of initial remission induction failure in acute myelogenous leukemia. Blood 1982; 60: 309–315
   PubMed Web of Science ®Google Scholar
• Thaler M., Pastakia B., Shawker T. H., O'Leary T., Pizzo P. A. Hepatic candidiasis in cancer patients: The evolving picture of the syndrome. Ann. Intern. Med. 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Verdeguer A., Fernandez J. M., Esquembre C., Ferris J., Ruiz J. G., Castel V. Hepatosplenic candidiasis in children with acute leukemia. Cancer 1990; 65: 874–877
   PubMed Web of Science ®Google Scholar
• Young N. A., Kwon-Chung K. J., Kubota T. T., Jennings A. E., Fisher R. I. Disseminated infection by Fusarium momliforme during treatment for malignant lymphoma. J. Clin. Microbiol 1978; 7: 589–594
   PubMed Web of Science ®Google Scholar
• Wheeler M. S., McGinnis M. R., Schell W. A., Walker D. H. Fusarium infection in burned patients. Am. J. Clin. Pathol. 1981; 75: 304–311
   PubMed Web of Science ®Google Scholar
• Valenstein P., Schell W. A. Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomycosis. Arch. Pathol. Lab. Med. 1986; 110: 751–754
   PubMed Web of Science ®Google Scholar
• Wiebe V. J., DeGregorio M. W. Liposome-encapsulated amphotericin B: A promising new treatment for disseminated fungal infections. Rev. Infect. Dis. 1988; 10: 1097–1101
   PubMedGoogle Scholar
• Lopez-Berestein G., Bodey G. P., Fainstein V., Keating M., Frankel L. S., Zeluff B., Gentry L., Mehta K. Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med. 1989; 149: 2533–2536
   PubMed Web of Science ®Google Scholar
• Janoff A. S., Boni L. T., Popescu M C., et al. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Natl. Acad. Sci. USA 1988; 85: 6122–6126
   PubMed Web of Science ®Google Scholar
• Guo L. S. S., Fielding R. M., Lasic D. D., Hamilton R. L., Mufson D. Novel antifungal drug delivery: Stable amphotericin B-cholesteryl sulfate discs. Int. J. Pharmaceut. 1991; 75: 45–54
   Web of Science ®Google Scholar
• Shapiro M., Ne'eman D., Rachmilewitz E. A., Sacks T., Barenholz Y. Use of amphotericin B colloidal dispersion (ABCD) in the treatment of invasive fungal disease in immunosuppressed hosts. 1992, Submitted for publication
   Google Scholar
• Amselem S., Cohen R., Druckman S., Gabizon A., Goren D., Abra R. M., Huang A., New R., Barenholz Y. Preparation and characterization of liposomal doxofubicin for tumor use. J. Liposome Res. 1992; 29(2)93–-123
   Google Scholar
• Senior J. H. Fate and behavior of liposomes in Vivo: A Review on controlling factors. Crt Rev on Therap: Drug. Carrier Systems 1987; 3: 123–193
   PubMed Web of Science ®Google Scholar